Taysha Gene Therapies Inc... (TSHA)
NASDAQ: TSHA
· Real-Time Price · USD
3.15
0.23 (7.88%)
At close: Sep 24, 2025, 3:59 PM
3.13
-0.68%
Pre-market: Sep 25, 2025, 08:08 AM EDT
7.88% (1D)
| Bid | 3.01 |
| Market Cap | 747.99M |
| Revenue (ttm) | 8.1M |
| Net Income (ttm) | -92.72M |
| EPS (ttm) | -0.34 |
| PE Ratio (ttm) | -9.26 |
| Forward PE | -7.12 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.29 |
| Volume | 4,763,969 |
| Avg. Volume (20D) | 3,143,684 |
| Open | 2.92 |
| Previous Close | 2.92 |
| Day's Range | 2.92 - 3.16 |
| 52-Week Range | 1.05 - 3.40 |
| Beta | 0.96 |
| Ex-Dividend Date | n/a |
About TSHA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TSHA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TSHA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsTaysha Gene Therapies Inc. is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+12.7%
Taysha Gene Therapies shares are trading higher af...
Unlock content with
Pro Subscription
3 months ago
-6.51%
Taysha Gene Therapies shares are trading higher. The company announced a proposed public offering of common stock.
1 month ago · seekingalpha.com
Taysha Gene Therapies, Inc. (TSHA) Q2 2025 Earnings Call TranscriptTaysha Gene Therapies, Inc. (NASDAQ:TSHA ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Hayleigh Collins - Director of Corporate Communications & Investor Relations...
